Merck & Co, Indian Firms On Tackling Supply Chain Risks And A Hijack

Visibility And Digitization Are Key

 
• By Anju Ghangurde

Merck & Co. executive outlines how the company could sustain a “compliant supply performance” amid the pandemic, while senior officials from Sun Pharma, Cipla, Zydus Cadila and Biocon shared insights on coping with supply chain turbulence and moving away from over-dependence on China for starting materials.

Shipping & Map image

Senior executives from Merck & Co., Inc. and several leading Indian pharma firms have shared insights around how they built supply chain resilience against the backdrop of the general turmoil during the early days of COVID-19. The experiences were also dotted with interesting real world vignettes, including the hijack of a pharma cargo truck in India.

Addressing the recently concluded BioAsia 2021 virtual event, Sanat Chattopadhyay, executive vice-president and president, Merck Manufacturing Division, noted the pandemic...

More from COVID-19

More from In Vivo

BioBytes: AI-Related Deals In Q2 ‘25

 
• By David Wild

When it came to AI-related deals, the second quarter of 2025 was characterized by mostly modest financings.

Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 
• By Eleanor Malone, Edwin Elmhirst, and Kosh Naran

The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.

Thinking Outside The BIOX: Bioxodes Takes Novel Approach To Intracerebral Hemorrhage

 
• By Jo Shorthouse

Although intracerebral hemorrhage accounts for only 13% of all strokes, it is responsible for approximately 40% of stroke-related deaths. A Belgian biotech is looking in unusual places to rectify this situation, namely in a tick’s mouth.